These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 29210217

  • 1. I131 reinforces antitumor activity of metuximab by reversing epithelial-mesenchymal transition via VEGFR-2 signaling in hepatocellular carcinoma.
    Wu L, Sun B, Lin X, Liu C, Qian H, Chen L, Yang Y, Shen F, Su C.
    Genes Cells; 2018 Jan; 23(1):35-45. PubMed ID: 29210217
    [Abstract] [Full Text] [Related]

  • 2. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 3. Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes.
    Wang J, Wu Z, Pan G, Ni J, Xie F, Jiang B, Wei L, Gao J, Zhou W.
    Nanomedicine; 2018 Aug; 14(6):1949-1961. PubMed ID: 29045824
    [Abstract] [Full Text] [Related]

  • 4. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
    Liu Y, Cheng DH, Lai KD, Su H, Lu GS, Wang L, Lv JH.
    Drug Des Devel Ther; 2021 Aug; 15():4885-4899. PubMed ID: 34880599
    [Abstract] [Full Text] [Related]

  • 5. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H.
    Sci Rep; 2017 Jan 30; 7():41616. PubMed ID: 28134289
    [Abstract] [Full Text] [Related]

  • 6. Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis.
    Cai K, Fang Y, Zhang Y, Liu J, Ye Q, Ding L, Cai X.
    PLoS One; 2024 Jan 30; 19(9):e0310391. PubMed ID: 39302935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma.
    Yin Y, Guo J, Teng F, Yu L, Jiang Y, Xie K, Jiang M, Fang J.
    Drug Des Devel Ther; 2019 Jan 30; 13():4173-4184. PubMed ID: 31849449
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
    Liu L, Qin S, Zheng Y, Han L, Zhang M, Luo N, Liu Z, Gu N, Gu X, Yin X.
    Cancer Biol Ther; 2017 Mar 04; 18(3):166-176. PubMed ID: 28368741
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells.
    Kim JO, Kim KH, Song IS, Cheon KS, Kim OH, Lee SC, Lee SK, Kim SJ.
    Oncotarget; 2017 Jan 10; 8(2):2936-2948. PubMed ID: 27935857
    [Abstract] [Full Text] [Related]

  • 15. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B.
    Oncol Rep; 2017 Aug 10; 38(2):1224-1232. PubMed ID: 28677802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
    Fu ZG, Wang L, Cui HY, Peng JL, Wang SJ, Geng JJ, Liu JD, Feng F, Song F, Li L, Zhu P, Jiang JL, Chen ZN.
    Oncotarget; 2016 Feb 23; 7(8):9429-47. PubMed ID: 26882566
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Volatile oil from Saussurea lappa exerts antitumor efficacy by inhibiting epithelial growth factor receptor tyrosine kinase-mediated signaling pathway in hepatocellular carcinoma.
    Lin X, Peng Z, Fu X, Liu C, Xu Y, Ji W, Fan J, Chen L, Fang L, Huang Y, Su C.
    Oncotarget; 2016 Nov 29; 7(48):79761-79773. PubMed ID: 27806329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.